Natera (NTRA Quick QuoteNTRA - Free Report) reported $413.35 million in revenue for the quarter ended June 2024, representing a year-over-year increase of 58.1%. EPS of -$0.30 for the same period compares to -$0.97 a year ago.

The reported revenue represents a surprise of +21.54% over the Zacks Consensus Estimate of $340.1 million. With the consensus EPS estimate being -$0.69, the EPS surprise was +56.52%.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Natera performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Tests Processed Volume

  : 760,300 versus 680,515 estimated by three analysts on average.

• Revenues- Product

  : $411.36 million compared to the $333.55 million average estimate based on four analysts. The reported number represents a change of +59.3% year over year.

• Revenues- Licensing and other

  : $1.99 million versus $3.27 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a -36.9% change.

View all Key Company Metrics for Natera here>>>

Shares of Natera have returned -10.1% over the past month versus the Zacks S&P 500 composite's -6.5% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.